Latest Articles
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Latest Results Presented at World Congress - ABN Newswire
Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerEndo Latest Results Presented at World Congress ABN Newswire
Published: May 25, 2025, 10:21 p.m.
Trump administration must restore health articles scrubbed for transgender mentions, judge rules - MSN
Trump administration must restore health articles scrubbed for transgender mentions, judge rules MSN
Published: May 25, 2025, 10:55 a.m.
Federal judge gives Trump administration 7 days to restore LGBTQ+ research by two Harvard doctors to website - The Boston Globe
Federal judge gives Trump administration 7 days to restore LGBTQ+ research by two Harvard doctors to website The Boston Globe
Published: May 23, 2025, 10:46 p.m.
Trump administration must restore health articles scrubbed for transgender mentions, judge rules - Yahoo News Canada
Trump administration must restore health articles scrubbed for transgender mentions, judge rules Yahoo News Canada
Published: May 23, 2025, 8:43 p.m.
Judge orders Trump administration to restore transgender health web pages - Washington Times
Judge orders Trump administration to restore transgender health web pages Washington Times
Published: May 23, 2025, 8:12 p.m.
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment - TipRanks
Genmab’s Rina-S: Promising Efficacy and Strategic Growth Potential in Endometrial Cancer Treatment TipRanks
Published: May 23, 2025, 10:59 a.m.
Trina Mansour, MD, highlights surgical strategies for managing endometriosis - Contemporary OB/GYN
Trina Mansour, MD, highlights surgical strategies for managing endometriosis Contemporary OB/GYN
Published: May 20, 2025, 9:14 p.m.
Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification - Nature
Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification Nature
Published: May 20, 2025, 7:23 p.m.
MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY - BioSpace
MAIPL THERAPEUTICS, INC. FORMS STRATEGIC ALLIANCE WITH ENDOSURE, INC. TO FACILITATE FIRST‑IN‑HUMAN TRIAL OF NOVEL NON‑HORMONAL ENDOMETRIOSIS THERAPY BioSpace
Published: May 20, 2025, 12:52 p.m.
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 - Morningstar
Eisai Demonstrates Commitment to Oncology Innovation at ASCO 2025 Morningstar
Published: May 20, 2025, 12:08 p.m.
Link copied to clipboard!